Editas Medicine, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Editas Medicine, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Editas Medicine, Inc. Return On Equity for the quarter ending September 30, 2024 was -80.1 %, a 47.7% decline year-over-year.
  • Editas Medicine, Inc. annual Return On Equity for 2023 was -43 %, a 14.6% increase from 2022.
  • Editas Medicine, Inc. annual Return On Equity for 2022 was -50.3 %, a 56.2% decline from 2021.
  • Editas Medicine, Inc. annual Return On Equity for 2021 was -32.2 %, a 3.84% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -43 +7.33 +14.6% Jan 1, 2023 Dec 31, 2023
2022 -50.3 -18.1 -56.2% Jan 1, 2022 Dec 31, 2022
2021 -32.2 -1.19 -3.84% Jan 1, 2021 Dec 31, 2021
2020 -31 +29.6 +48.8% Jan 1, 2020 Dec 31, 2020
2019 -60.6 -13.8 -29.5% Jan 1, 2019 Dec 31, 2019
2018 -46.8 +15.1 +24.4% Jan 1, 2018 Dec 31, 2018
2017 -61.9 -5.86 -10.5% Jan 1, 2017 Dec 31, 2017
2016 -56.1 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.